Hypertensive Pregnancy Disorders and Lipid Profiles: A Cohort Study
Abstract
Background: The global prevalence of hypertensive pregnancy disorders (HPDs) is 5.2%-8.2%. Lipid profiles made up of triglycerides (TG), total cholesterol (TC), low-density lipoprotein-cholesterol (LDL), and high-density lipoprotein-cholesterol (HDL) could affect the arterial vessel wall leading to HPDs. Preeclampsia (PE), among the most severe maternal-fetal HPDs, has affected 0.2%-9.2% of all pregnancies. The current study aimed to investigate the role of lipid profiles in predicting PE in the first and early third trimesters of pregnancy. Material and Method: A large-scale prospective cohort study was conducted from early pregnancy onward in a normal population in the south of Iran. Fasting blood samples were examined for TG, TC, HDL, and LDL, as well as LDL/HDL ratio levels in the first and early third trimesters. Result: Of 486 pregnant women, 37 women developed HPDs, of which 20 (54%) developed PE. In the PE group, the levels of serum lipid profiles, including TG, TC, LDL, and HDL, significantly raised with gestational age (P<0.05). After adjusting for maternal age and body mass index, TG, TC, LDL, and LDL/HDL ratio levels were associated with a higher risk of PE (odds ratio [OR]=1.025, 1.035, 1.03, 2.08, and 1.026, 1.044, 1.03, 2.14, P<0.001) regarding the first and early third trimesters, respectively. The optimum cut-off points for TG, TC, LDL, and LDL/HDL ratios predicting PE were estimated to be 180.5 mg/dl, 197.5 mg/dl, 136 mg/dl, and 3.66 in the first, and 220 mg/dl, 204 mg/dl, 155.5 mg/dl, and 3.97 in the early third trimesters. Conclusion: Dyslipidemia during pregnancy may help predict PE development that can be sustained with lipid-lowering drugs. [GMJ.2022;11:e2395]References
Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40(3):213-20.
https://doi.org/10.1038/hr.2016.126
PMid:27682655
Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1-7.
https://doi.org/10.1016/j.ejogrb.2013.05.005
PMid:23746796
Goldenberg RL, Jones B, Griffin JB, Rouse DJ, Kamath‐Rayne BD, Trivedi N, et al. Reducing maternal mortality from preeclampsia and eclampsia in low‐resource countries-what should work? Acta Obstet Gynecol Scand. 2015;94(2):148-55.
https://doi.org/10.1111/aogs.12533
PMid:25353716
Dassah ET, Kusi-Mensah E, Morhe ES, Odoi AT. Maternal and perinatal outcomes among women with hypertensive disorders in pregnancy in Kumasi, Ghana. PloS One. 2019;14(10):e0223478.
https://doi.org/10.1371/journal.pone.0223478
PMid:31584982 PMCid:PMC6777792
Karatza AA, Dimitriou G. Preeclampsia Emerging as a Novel Risk Factor for Cardiovascular Disease in the Offspring. Curr Pediatr Rev. 2020;16(3):194-9.
https://doi.org/10.2174/18756336MTAzlMTg3y
https://doi.org/10.2174/1573396316666191224092405
PMid:31884930 PMCid:PMC8193805
Kongwattanakul K, Saksiriwuttho P, Chaiyarach S, Thepsuthammarat K. Incidence, characteristics, maternal complications, and perinatal outcomes associated with preeclampsia with severe features and HELLP syndrome. Int J Womens Health. 2018;10:371-7.
https://doi.org/10.2147/IJWH.S168569
PMid:30046254 PMCid:PMC6054275
Maged AM, Elsherief A, Hassan H, Salaheldin D, Omran KA, Almohamady M, et al. Maternal, fetal, and neonatal outcomes among different types of hypertensive disorders associating pregnancy needing intensive care management. J Matern Fetal Med. 2020;33(2):314-21.
https://doi.org/10.1080/14767058.2018.1491030
PMid:29914278
Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97-104.
https://doi.org/10.1016/j.preghy.2014.02.001
PMid:26104417
Wang C, Kong L, Yang Y, Wei Y, Zhu W, Su R, et al. Recommended reference values for serum lipids during early and middle pregnancy: a retrospective study from China. Lipids Health Dis. 2018;17(1):1-16.
https://doi.org/10.1007/978-981-13-0620-4_1
https://doi.org/10.1186/s12944-015-0172-5
https://doi.org/10.1186/s12944-018-0885-3
https://doi.org/10.1186/s12944-018-0950-y
PMid:30611256 PMCid:PMC6320598
Singh A, Kujur A, Jain P. Feto-maternal impact of altered lipid profile in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2018;7(1):132-7.
https://doi.org/10.18203/2320-1770.ijrcog20175547
Ghodke B, Pusukuru R, Mehta V. Association of Lipid Profile in Pregnancy with Preeclampsia, Gestational Diabetes Mellitus, and Preterm Delivery. Cureus. 2017;9(7):e1420.
https://doi.org/10.7759/cureus.1420
PMid:28875093 PMCid:PMC5580975
Garcia MS, Mobley Y, Henson J, Davies M, Skariah A, Dambaeva S, et al. Early pregnancy immune biomarkers in peripheral blood may predict preeclampsia. J Reprod Immunol. 2018;125:25-31.
https://doi.org/10.1016/j.jri.2017.10.048
PMid:29161617
Staff A, Dechend R, Redman C. Preeclampsia, acute atherosis of the spiral arteries and future cardiovascular disease: two new hypotheses. Placenta. 2013;34:S73-8.
https://doi.org/10.1016/j.placenta.2012.11.022
PMid:23246096
Alonso-Ventura V, Li Y, Pasupuleti V, Roman YM, Hernandez AV, Pérez-López FR. Effects of preeclampsia and eclampsia on maternal metabolic and biochemical outcomes in later life: a systematic review and meta-analysis. Metabolism. 2020;102:154012.
https://doi.org/10.1016/j.metabol.2019.154012
PMid:31734276
Adank MC, Benschop L, Peterbroers KR, Smak Gregoor AM, Kors AW, Mulder MT, Schalekamp-Timmermans S, Roeters Van Lennep JE, Steegers EAP. Is maternal lipid profile in early pregnancy associated with pregnancy complications and blood pressure in pregnancy and long term postpartum? Am J Obstet Gynecol. 2019;221(2):150.e1-13.
https://doi.org/10.1016/j.ajog.2019.03.025
PMid:30940559
Esteve-Valverde E, Ferrer-Oliveras R, Gil-Aliberas N, Baraldes-Farre A, Llurba E, Alijotas-Reig J. Pravastatin for Preventing and Treating Preeclampsia: A Systematic Review. Obstet Gynecol Surv. 2018;73(1):40-55.
https://doi.org/10.1097/OGX.0000000000000522
PMid:29368790
Bauersachs J, König T, Van Der Meer P, Petrie MC, Hilfiker‐Kleiner D, Mbakwem A, et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019;21(7):827-43.
https://doi.org/10.1002/ejhf.1493
PMid:31243866
Motedayen M, Rafiei M, Tavirani MR, Sayehmiri K, Dousti M. The relationship between body mass index and preeclampsia: A systematic review and meta-analysis. Int J Reprod Biomed. 2019;17(7):463.
https://doi.org/10.18502/ijrm.v17i7.4857
PMid:31508571 PMCid:PMC6718883
Poorolajal J, Jenabi E. The association between body mass index and preeclampsia: a meta-analysis. J Matern Fetal Neonatal Med. 2016;29(22):3670-6.
https://doi.org/10.3109/14767058.2016.1140738
PMid:26762770
Jin W-Y, Lin S-L, Hou R-L, Chen X-Y, Han T, Jin Y, et al. Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China. BMC Pregnancy Childbirth. 2016;16(1):1-9.
https://doi.org/10.1186/s12884-016-0852-9
PMid:27000102 PMCid:PMC4802610
Kumari K, Singh U, Maharshi S, Singh R. Assessment of serum lipid profile in early pregnancy and its relation with pre eclampsia: a prospective study. Int J Reprod Contracept Obstet Gynecol. 2016;5(3):840-5.
https://doi.org/10.18203/2320-1770.ijrcog20160595
Zheng T, Ye W, Wang X, Li X, Zhang J, Little J, et al. A simple model to predict risk of gestational diabetes mellitus from 8 to 20 weeks of gestation in Chinese women. BMC Pregnancy Childbirth. 2019;19(1):1-10.
https://doi.org/10.1186/s12884-019-2374-8
PMid:31324151 PMCid:PMC6642502
Chopra S, Pahwa S. Role of lipid profile and uterine artery doppler in predicting risk of preeclampsia in early second trimester. Int J Reprod Contracept Obstet Gynecol. 2020;9(5):1806-13.
https://doi.org/10.18203/2320-1770.ijrcog20201542
Murmu S, Dwivedi J. Second-Trimester Maternal Serum Beta-Human Chorionic Gonadotropin and Lipid Profile as a Predictor of Gestational Hypertension, Preeclampsia, and Eclampsia: A Prospective Observational Study. Int J Appl Basic Med Res. 2020;10(1):49-53. https://doi.org/10.4103/ijabmr.IJABMR_271_19
PMid:32002386 PMCid:PMC6967338
Pendli G, Chandana G, Balaji S, Varaprasad MD. A study of biochemical parameters in pregnant women in III trimester with non-alcoholic fatty liver disease (NAFLD). Biomedicine. 2021;41(2):199-205.
https://doi.org/10.51248/.v41i2.784
Tesfa E, Nibert E, Munshea A. Maternal lipid profile and risk of pre-eclampsia in African pregnant women: A systematic review and meta-analysis. PLoS One. 2020;15(12):e0243538.
https://doi.org/10.1371/journal.pone.0243538
PMid:33362205 PMCid:PMC7757810
Thathagari V, Kumar VJIJRCOG. Evaluation of serum lipids in preeclampsia: a comparative study. Int J Reprod Contracept Obstet Gynecol. 2018;7(4):1372-5.
https://doi.org/10.18203/2320-1770.ijrcog20180998
Yadav S, Agrawal M, Hariharan C, Dewani D, Vadera K, Krishna NJJoDMIoMSU. A comparative study of serum lipid profile of women with preeclampsia and normotensive pregnancy. J Obstet Gynaecol India. 2018;13(2):83.
https://doi.org/10.4103/jdmimsu.jdmimsu_70_17
Majhi B. Role of lipid profile in early second trimester for prediction of pre-eclampsia. Int J Reprod Contracept Obstet Gynecol. 2021;10(8):3101-6.
https://doi.org/10.18203/2320-1770.ijrcog20212962
Yadav K, Aggarwal S, Verma K. Serum βhCG and lipid profile in early second trimester as predictors of pregnancy-induced hypertension. J Obstet Gynaecol India. 2014;64(3):169-74.
https://doi.org/10.1007/s13224-013-0490-3
PMid:24966499 PMCid:PMC4061328
Copyright (c) 2022 Galen Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
